Skip to main content

Animations

MJFF Publications

5731 - 5740 of 6467 Results
Title
Year
  • Year
  • 2017
  • 2020
  • 2022
  • 2020
  • 2021
  • 2014
  • 2024
  • 2020
  • 2024
  • 2024
  • Summary Details
    OPEN
    Title: The nasal and gut microbiome in Parkinson's disease and idiopathic rapid eye movement sleep behavior disorder
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.27105
    Citation Count: 569
  • Summary Details
    OPEN
    Title: Immunohistochemical Detection of Synuclein Pathology in Skin in Idiopathic Rapid Eye Movement Sleep Behavior Disorder and Parkinsonism
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.28399
    Citation Count: 59
  • Summary Details
    OPEN
    Title: Disruption of Mitochondrial Complex I Induces Progressive Parkinsonism
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.28961
    Citation Count: 15
  • Summary Details
    OPEN
    Title: Large-scale pathway specific polygenic risk and transcriptomic community network analysis identifies novel functional pathways in Parkinson disease
    Journal Name: Acta Neuropathologica
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00401-020-02181-3
    Citation Count: 119
  • Summary Details
    OPEN
    Title: 32nd International Symposium on the Autonomic Nervous System
    Journal Name: Clinical Autonomic Research
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s10286-021-00822-5
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Cerebrospinal Fluid α-Synuclein Predicts Cognitive Decline in Parkinson Disease Progression in the DATATOP Cohort
    Journal Name: The American Journal of Pathology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.ajpath.2013.12.007
    Citation Count: 142
  • Summary Details
    OPEN
    Title: Longitudinal prevalence of neurogenic orthostatic hypotension in the idiopathic Parkinson Progression Marker Initiative (PPMI) cohort
    Journal Name: Autonomic Neuroscience
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.autneu.2024.103173
    Citation Count: 12
  • Summary Details
    OPEN
    Title: Efficacy of Nilotinib in Patients With Moderately Advanced Parkinson Disease
    Journal Name: JAMA Neurology
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1001/jamaneurol.2020.4725
    Citation Count: 146
  • Summary Details
    OPEN
    Title: Unfolded protein response markers Grp78 and eIF2alpha are upregulated with increasing alpha‐synuclein levels in Lewy body disease
    Journal Name: Neuropathology and Applied Neurobiology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1111/nan.12999
    Citation Count: 10
  • Summary Details
    OPEN
    Title: Data‐driven disease progression model of Parkinson's disease and effect of sex and genetic variants
    Journal Name: CPT: Pharmacometrics & Systems Pharmacology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/psp4.13112
    Citation Count: 11
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.